Global Ocular Drug Delivery Sales Market Report 2021

1 Ocular Drug Delivery Market Overview

• 1.1 Ocular Drug Delivery Product Scope
• 1.2 Ocular Drug Delivery Segment by Type
  • 1.2.1 Global Ocular Drug Delivery Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Ocular Insert
  • 1.2.3 Iontophoresis
  • 1.2.4 Intraocular Implants
  • 1.2.5 In Situ Gel & Punctal Plugs
  • 1.2.6 Others
• 1.3 Ocular Drug Delivery Segment by Application
  • 1.3.1 Global Ocular Drug Delivery Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Hospitals
  • 1.3.3 Ambulatory Surgical Centers
  • 1.3.4 Ophthalmic Clinics
  • 1.3.5 Homecare Settings
• 1.4 Ocular Drug Delivery Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Ocular Drug Delivery Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Ocular Drug Delivery Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Ocular Drug Delivery Price Trends (2016-2027)

2 Ocular Drug Delivery Estimates and Forecasts by Region

• 2.1 Global Ocular Drug Delivery Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Ocular Drug Delivery Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Ocular Drug Delivery Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Ocular Drug Delivery Revenue Market Share by Region (2016-2021)
• 2.3 Global Ocular Drug Delivery Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Ocular Drug Delivery Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Ocular Drug Delivery Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Ocular Drug Delivery Estimates and Projections (2016-2027)
  • 2.4.2 Europe Ocular Drug Delivery Estimates and Projections (2016-2027)
  • 2.4.3 China Ocular Drug Delivery Estimates and Projections (2016-2027)
  • 2.4.4 Japan Ocular Drug Delivery Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Ocular Drug Delivery Estimates and Projections (2016-2027)
  • 2.4.6 India Ocular Drug Delivery Estimates and Projections (2016-2027)

3 Global Ocular Drug Delivery Competition Landscape by Players

• 3.1 Global Top Ocular Drug Delivery Players by Sales (2016-2021)
• 3.2 Global Top Ocular Drug Delivery Players by Revenue (2016-2021)
• 3.3 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ocular Drug Delivery as of 2020)
• 3.4 Global Ocular Drug Delivery Average Price by Company (2016-2021)
• 3.5 Manufacturers Ocular Drug Delivery Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Ocular Drug Delivery Market Size by Type

• 4.1 Global Ocular Drug Delivery Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Ocular Drug Delivery Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Ocular Drug Delivery Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Ocular Drug Delivery Price by Type (2016-2021)
• 4.2 Global Ocular Drug Delivery Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Ocular Drug Delivery Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Ocular Drug Delivery Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Ocular Drug Delivery Price Forecast by Type (2022-2027)

5 Global Ocular Drug Delivery Market Size by Application

• 5.1 Global Ocular Drug Delivery Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Ocular Drug Delivery Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Ocular Drug Delivery Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Ocular Drug Delivery Price by Application (2016-2021)
• 5.2 Global Ocular Drug Delivery Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Ocular Drug Delivery Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Ocular Drug Delivery Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Ocular Drug Delivery Price Forecast by Application (2022-2027)

6 North America Ocular Drug Delivery Market Facts & Figures

• 6.1 North America Ocular Drug Delivery Sales by Company
  • 6.1.1 North America Ocular Drug Delivery Sales by Company (2016-2021)
  • 6.1.2 North America Ocular Drug Delivery Revenue by Company (2016-2021)
• 6.2 North America Ocular Drug Delivery Sales Breakdown by Type
  • 6.2.1 North America Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
• 6.3 North America Ocular Drug Delivery Sales Breakdown by Application
  • 6.3.1 North America Ocular Drug Delivery Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Ocular Drug Delivery Sales Breakdown by Application (2022-2027)

7 Europe Ocular Drug Delivery Market Facts & Figures

• 7.1 Europe Ocular Drug Delivery Sales by Company
  • 7.1.1 Europe Ocular Drug Delivery Sales by Company (2016-2021)
  • 7.1.2 Europe Ocular Drug Delivery Revenue by Company (2016-2021)
• 7.2 Europe Ocular Drug Delivery Sales Breakdown by Type
  • 7.2.1 Europe Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
• 7.3 Europe Ocular Drug Delivery Sales Breakdown by Application
  • 7.3.1 Europe 125 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 125 Sales Breakdown by Application (2022-2027)

8 China Ocular Drug Delivery Market Facts & Figures

• 8.1 China Ocular Drug Delivery Sales by Company
  • 8.1.1 China Ocular Drug Delivery Sales by Company (2016-2021)
  • 8.1.2 China Ocular Drug Delivery Revenue by Company (2016-2021)
• 8.2 China Ocular Drug Delivery Sales Breakdown by Type
  • 8.2.1 China Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
• 8.3 China Ocular Drug Delivery Sales Breakdown by Application
  • 8.3.1 China 154 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 154 Sales Breakdown by Application (2022-2027)

9 Japan Ocular Drug Delivery Market Facts & Figures

• 9.1 Japan Ocular Drug Delivery Sales by Company
  • 9.1.1 Japan Ocular Drug Delivery Sales by Company (2016-2021)
  • 9.1.2 Japan Ocular Drug Delivery Revenue by Company (2016-2021)
• 9.2 Japan Ocular Drug Delivery Sales Breakdown by Type
  • 9.2.1 Japan Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
• 9.3 Japan Ocular Drug Delivery Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Ocular Drug Delivery Market Facts & Figures

• 10.1 Southeast Asia Ocular Drug Delivery Sales by Company
  • 10.1.1 Southeast Asia Ocular Drug Delivery Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Ocular Drug Delivery Revenue by Company (2016-2021)
• 10.2 Southeast Asia Ocular Drug Delivery Sales Breakdown by Type
  • 10.2.1 Southeast Asia Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Ocular Drug Delivery Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Ocular Drug Delivery Market Facts & Figures

• 11.1 India Ocular Drug Delivery Sales by Company
  • 11.1.1 India Ocular Drug Delivery Sales by Company (2016-2021)
  • 11.1.2 India Ocular Drug Delivery Revenue by Company (2016-2021)
• 11.2 India Ocular Drug Delivery Sales Breakdown by Type
  • 11.2.1 India Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
• 11.3 India Ocular Drug Delivery Sales Breakdown by Application
  • 11.3.1 India Ocular Drug Delivery Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Ocular Drug Delivery Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Ocular Drug Delivery Business

• 12.1 OCULAR THERAPEUTIX, INC
  • 12.1.1 OCULAR THERAPEUTIX, INC Corporation Information
  • 12.1.2 OCULAR THERAPEUTIX, INC Business Overview
  • 12.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
  • 12.1.5 OCULAR THERAPEUTIX, INC Recent Development
• 12.2 Alimera Sciences
  • 12.2.1 Alimera Sciences Corporation Information
  • 12.2.2 Alimera Sciences Business Overview
  • 12.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Alimera Sciences Ocular Drug Delivery Products Offered
  • 12.2.5 Alimera Sciences Recent Development
• 12.3 Allergan, Plc
  • 12.3.1 Allergan, Plc Corporation Information
  • 12.3.2 Allergan, Plc Business Overview
  • 12.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Allergan, Plc Ocular Drug Delivery Products Offered
  • 12.3.5 Allergan, Plc Recent Development
• 12.4 EyeGate Pharma
  • 12.4.1 EyeGate Pharma Corporation Information
  • 12.4.2 EyeGate Pharma Business Overview
  • 12.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 EyeGate Pharma Ocular Drug Delivery Products Offered
  • 12.4.5 EyeGate Pharma Recent Development
• 12.5 Valeant Pharmaceuticals International, Inc
  • 12.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
  • 12.5.2 Valeant Pharmaceuticals International, Inc Business Overview
  • 12.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Products Offered
  • 12.5.5 Valeant Pharmaceuticals International, Inc Recent Development
• 12.6 Envisia Therapeutics
  • 12.6.1 Envisia Therapeutics Corporation Information
  • 12.6.2 Envisia Therapeutics Business Overview
  • 12.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Envisia Therapeutics Ocular Drug Delivery Products Offered
  • 12.6.5 Envisia Therapeutics Recent Development
• 12.7 Clearside Biomedical
  • 12.7.1 Clearside Biomedical Corporation Information
  • 12.7.2 Clearside Biomedical Business Overview
  • 12.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Clearside Biomedical Ocular Drug Delivery Products Offered
  • 12.7.5 Clearside Biomedical Recent Development
• 12.8 Graybug Vision Inc
  • 12.8.1 Graybug Vision Inc Corporation Information
  • 12.8.2 Graybug Vision Inc Business Overview
  • 12.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Graybug Vision Inc Ocular Drug Delivery Products Offered
  • 12.8.5 Graybug Vision Inc Recent Development
• 12.9 Taiwan Liposome Company
  • 12.9.1 Taiwan Liposome Company Corporation Information
  • 12.9.2 Taiwan Liposome Company Business Overview
  • 12.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Taiwan Liposome Company Ocular Drug Delivery Products Offered
  • 12.9.5 Taiwan Liposome Company Recent Development
• 12.10 Santen Pharmaceutical
  • 12.10.1 Santen Pharmaceutical Corporation Information
  • 12.10.2 Santen Pharmaceutical Business Overview
  • 12.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Santen Pharmaceutical Ocular Drug Delivery Products Offered
  • 12.10.5 Santen Pharmaceutical Recent Development

13 Ocular Drug Delivery Manufacturing Cost Analysis

• 13.1 Ocular Drug Delivery Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Ocular Drug Delivery
• 13.4 Ocular Drug Delivery Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Ocular Drug Delivery Distributors List
• 14.3 Ocular Drug Delivery Customers

15 Market Dynamics

• 15.1 Ocular Drug Delivery Market Trends
• 15.2 Ocular Drug Delivery Drivers
• 15.3 Ocular Drug Delivery Market Challenges
• 15.4 Ocular Drug Delivery Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List